GlassScriptPhysician profile
Daniel Jose Lopez
NPI 1760011845
$11,224.72
in general payments reported to CMS, 2019-2025
11 companies · $2,354 in 2025
The $2,354 reported for 2025 was more than what 81% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.63 · 2023: $5,697 · 2024: $3,091 · 2025: $2,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,917 · Grant: $3,750 · Food and Beverage: $2,362 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,916.72 |
| Grant | $3,750.00 |
| Food and Beverage | $2,362.04 |
| Education | $112.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,561.53 | 2023-2025 | Wavewriter Alpha Prime 16, Vercise, Intracept |
| Curonix LLC | $1,108.61 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $1,066.96 | 2024-2025 | Proclaim, Eterna |
| Medtronic, INC. | $991.74 | 2022-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $259.80 | 2024-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Stryker Corporation | $33.88 | 2023 | Spinejack |
| Si-Bone, INC. | $28.06 | 2025 | |
| Almatica Pharma LLC | $22.23 | 2023 | Loreev Xr, Sertraline Hcl, Gralise |
| Nevro Corp. | $17.66 | 2023 | Senza |
| Nalu Medical, INC. | $17.30 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.